Molecular similarity in medicinal chemistry.
暂无分享,去创建一个
[1] A. Tversky. Features of Similarity , 1977 .
[2] K. Sen,et al. Molecular Similarity I , 1995 .
[3] Robert D Clark,et al. Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.
[4] M. Lajiness. Dissimilarity-based compound selection techniques , 1996 .
[5] Yvonne C. Martin,et al. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..
[6] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[7] J. C. BurgesChristopher. A Tutorial on Support Vector Machines for Pattern Recognition , 1998 .
[8] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[9] James T. Becker,et al. Working Memory(s) , 1999, Brain and Cognition.
[10] S. Young,et al. Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning. , 2000 .
[11] A. Good,et al. 3-D pharmacophores in drug discovery. , 2001, Current pharmaceutical design.
[12] Andrew C. Good,et al. Explicit Calculation of 3D Molecular Similarity , 2002 .
[13] Peter Willett,et al. Maximum common subgraph isomorphism algorithms for the matching of chemical structures , 2002, J. Comput. Aided Mol. Des..
[14] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[15] Hugo Kubinyi,et al. Similarity and Dissimilarity: A Medicinal Chemist’s View , 2002 .
[16] Joseph S. Verducci,et al. A Modification of the Jaccard–Tanimoto Similarity Index for Diverse Selection of Chemical Compounds Using Binary Strings , 2002, Technometrics.
[17] J. Gasteiger,et al. Neural networks as data mining tools in drug design , 2003 .
[18] Susumu Yamanobe,et al. Development of a Method for Evaluating Drug‐Likeness and Ease of Synthesis Using a Data Set in which Compounds Are Assigned Scores Based on Chemists′ Intuition. , 2003 .
[19] Michael S Lajiness,et al. Assessment of the consistency of medicinal chemists in reviewing sets of compounds. , 2004, Journal of medicinal chemistry.
[20] G. Maggiora,et al. Molecular similarity measures. , 2004, Methods in molecular biology.
[21] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[22] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[23] A. Fliri,et al. Biological spectra analysis: Linking biological activity profiles to molecular structure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[25] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[26] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[27] W. Kolanus. Guanine nucleotide exchange factors of the cytohesin family and their roles in signal transduction , 2007, Immunological reviews.
[28] Robert P Sheridan,et al. Chemical similarity searches: when is complexity justified? , 2007, Expert opinion on drug discovery.
[29] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[30] Jürgen Bajorath,et al. Apparent Asymmetry in Fingerprint Similarity Searching is a Direct Consequence of Differences in Bit Densities and Molecular Size , 2007, ChemMedChem.
[31] Jürgen Bajorath,et al. Emerging Chemical Patterns: A New Methodology for Molecular Classification and Compound Selection. , 2007 .
[32] Robert P. Sheridan,et al. Comparison of Topological, Shape, and Docking Methods in Virtual Screening. , 2007 .
[33] Valerie J Gillet,et al. A Comparison of Field-Based Similarity Searching Methods: CatShape, FBSS, and ROCS , 2008, J. Chem. Inf. Model..
[34] N. Cowan. What are the differences between long-term, short-term, and working memory? , 2008, Progress in brain research.
[35] Herbert Köppen. Virtual screening - what does it give us? , 2009, Current opinion in drug discovery & development.
[36] Gary Tresadern,et al. Modeling approaches for ligand-based 3D similarity. , 2010, Future medicinal chemistry.
[37] Andreas Bender,et al. How similar are those molecules after all? Use two descriptors and you will have three different answers , 2010, Expert opinion on drug discovery.
[38] J. Bajorath,et al. Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. , 2010, Journal of medicinal chemistry.
[39] J. Bajorath,et al. Global assessment of scaffold hopping potential for current pharmaceutical targets , 2010 .
[40] Jürgen Bajorath,et al. Advanced fingerprint methods for similarity searching: balancing molecular complexity effects. , 2010, Combinatorial chemistry & high throughput screening.
[41] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[42] Hanna Geppert,et al. Targeting multifunctional proteins by virtual screening: structurally diverse cytohesin inhibitors with differentiated biological functions. , 2010, ACS chemical biology.
[43] J. Bajorath,et al. Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.
[44] Jürgen Bajorath,et al. Rendering Conventional Molecular Fingerprints for Virtual Screening Independent of Molecular Complexity and Size Effects , 2010, ChemMedChem.
[45] Jürgen Bajorath,et al. Similarity searching , 2011 .
[46] Valerie J. Gillet,et al. Diversity selection algorithms , 2011 .
[47] Peter S. Kutchukian,et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.
[48] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[49] Jürgen Bajorath,et al. Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.
[50] Ulrike Hahn,et al. Similarity-based asymmetries in perceptual matching. , 2012, Acta psychologica.
[51] Meir Glick,et al. Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery , 2012, PloS one.
[52] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[53] José L. Medina-Franco,et al. MOLECULAR SIMILARITY ANALYSIS , 2013 .
[54] Jürgen Bajorath,et al. Quantifying the Fingerprint Descriptor Dependence of Structure-Activity Relationship Information on a Large Scale , 2013, J. Chem. Inf. Model..
[55] J. Bajorath,et al. Compound promiscuity: what can we learn from current data? , 2013, Drug discovery today.
[56] Peter Willett,et al. Combination of Similarity Rankings Using Data Fusion , 2013, J. Chem. Inf. Model..
[57] Jürgen Bajorath,et al. Recent progress in understanding activity cliffs and their utility in medicinal chemistry. , 2014, Journal of medicinal chemistry.